India Court Allows Dr. Reddy’s to Export Generics of Novo Nordisk’s Semaglutide Drug
Semaglutide is the main ingredient in Novo’s diabetes medicine Ozempic and its weight-loss drug Wegovy.
Photographer: Shelby Knowles/Bloomberg
Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here.